It has been shown that NLRP3 is elevated in patients with Alzheimer’s disease (39), viral encephalitis (40), MS (41), traumatic brain injury (42), stroke (43), Parkinson’s disease (44), epilepsy (45), and other diseases. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.